Literature DB >> 8603689

Effects of beta cell granule components on human islet amyloid polypeptide fibril formation.

P Westermark1, Z C Li, G T Westermark, A Leckström, D F Steiner.   

Abstract

Formation of amyloid-like fibrils in a solution of human islet amyloid polypeptide (hIAPP) with and without the presence of other beta-cell granule components was studied in vitro. Insulin at less than equimolar concentration strongly inhibited hIAPP fibrillogenesis. Proinsulin had a weaker inhibitory effect while C-peptide, Ca2+ and Zn2+ each individually enhanced fibril formation. C-peptide combined with Ca2+ had an inhibitory effect. Since IAPP was found almost exclusively in the halo fractions of isolated islet secretory granules, primarily the concentrations of C-peptide, Ca2+ and possibly proinsulin may be crucial for the native state of IAPP. It is concluded that an imbalance between fibril formation enhancers and inhibitors may be of importance in the pathogenesis of amyloid in the islets of Langerhans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603689     DOI: 10.1016/0014-5793(95)01512-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  62 in total

1.  Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model.

Authors:  Chengyang Liu; Brigitte Koeberlein; Michael D Feldman; Rebecca Mueller; Zhonglin Wang; Yanjing Li; Kristin Lane; Clifford C Hoyt; John E Tomaszewski; Ali Naji; Michael R Rickels
Journal:  Endocrinology       Date:  2012-02-21       Impact factor: 4.736

Review 2.  Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?

Authors:  Per Westermark; Arne Andersson; Gunilla T Westermark
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

3.  Biphasic effects of insulin on islet amyloid polypeptide membrane disruption.

Authors:  Jeffrey R Brender; Edgar L Lee; Kevin Hartman; Pamela T Wong; Ayyalusamy Ramamoorthy; Duncan G Steel; Ari Gafni
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

4.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.

Authors:  Maarten F M Engel; Lucie Khemtémourian; Cécile C Kleijer; Hans J D Meeldijk; Jet Jacobs; Arie J Verkleij; Ben de Kruijff; J Antoinette Killian; Jo W M Höppener
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-11       Impact factor: 11.205

Review 5.  Misfolded proteins in Alzheimer's disease and type II diabetes.

Authors:  Alaina S DeToma; Samer Salamekh; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Chem Soc Rev       Date:  2011-08-04       Impact factor: 54.564

6.  The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors.

Authors:  Ping Cao; Fanling Meng; Andisheh Abedini; Daniel P Raleigh
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

7.  Solution state structures of human pancreatic amylin and pramlintide.

Authors:  John R Cort; Zhihong Liu; Gregory M Lee; K N L Huggins; Susan Janes; Kathryn Prickett; Niels H Andersen
Journal:  Protein Eng Des Sel       Date:  2009-07-12       Impact factor: 1.650

Review 8.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

9.  Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS.

Authors:  Juan R Peinado; Furqan Sami; Nina Rajpurohit; Iris Lindberg
Journal:  FEBS Lett       Date:  2013-09-13       Impact factor: 4.124

Review 10.  Amyloid deposition in transplanted human pancreatic islets: a conceivable cause of their long-term failure.

Authors:  Arne Andersson; Sara Bohman; L A Håkan Borg; Johan F Paulsson; Sebastian W Schultz; Gunilla T Westermark; Per Westermark
Journal:  Exp Diabetes Res       Date:  2009-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.